Funding
Growth · Healthtech

Emboline receives $20M growth financing

Emboline received $20 million in growth financing announced in March, with Trinity Capital among its backers.

Updated Oct 16, 2026By RoundOS Funding desk

The company develops embolic-protection systems for transcatheter cardiovascular procedures.

Funding history

Growth · This round$20M

Sources

  1. Emboline, Inc.projectstartups.com
  2. prnewswire.com

Similar rounds

All Healthtech rounds →
Guoke Brain-Computer

Beijing startup developing non-invasive wearable brain-computer interfaces that combine brain-signal detection, decoding and neural modulation.

UndisclosedSeed · Oct 23, 2026
SEGNOS

SEGNOS develops magnetic-particle materials and diagnostic technologies for blood testing.

UndisclosedPre-Series A · Oct 22, 2026
CureBay

CureBay operates a hybrid healthcare network for rural and underserved communities in India.

~₹1BPre-Series C · Oct 22, 2026
iCUREX

Kagoshima medical-device company developing chitosan hydrogel materials for wound care, including the syringe-delivered Kitosla CX dressing.

¥140MSeries A first close: equity and debt · Oct 22, 2026

Related